Condition
Henoch Schönlein Purpura Nephritis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Henoch Schönlein Purpura Nephritis clinical trials that are recruiting, in China. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Personalized IgA Nephropathy treatment guided by Gd-IgA1 monitoring
This study tests whether regularly checking a biomarker called Gd-IgA1 to guide treatment with Nefecon or telitacicept helps people with IgA nephropathy or related nephritis respond better.
-
Finerenone treatment for children with Henoch–Schönlein purpura nephritis and mild proteinuria
This trial will test whether adding finerenone to standard ACEI/ARB therapy helps reduce protein in the urine and is safe for children aged 3 to 17 with HSPN and mild proteinuria.
Related topics
Quick answers
How many Henoch Schönlein Purpura Nephritis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.